Statistics for Cardlytics (id:6710 CDLX)

Valuation metrics

Market cap

186.52M

Enterprise value

333.34M

Trailing P/E (ttm)

-0.99

Forward P/E

-10.79

PEG ratio

-10.79

Price/Sales (ttm)

0.64

Price/Book (mrq)

2.65

Enterprise Value/Revenue

1.14

Enterprise Value/EBITDA

-9.11

Overview

Shares outstanding

50.82M

Float

43.24M

Shares short

7.10M

% Held by insiders

0.05%

% Held by institutions

0.62%

Average volume (10 days)

1.13M

Average volume (90 days)

Price summary

52-Week low

2.89

52-Week high

20.52

52-Week change

-113.35%

Beta

1.62

50-Day moving average

3.73

200-Day moving average

7.62

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-93.55%

Operating margin

-25.13%

Operational effectiveness

Return on assets

-7.62%

Return on equity

-186.12%

Income statement

Revenue (ttm)

6.46

Revenue per share (ttm)

6.46

Quarterly revenue growth (yoy)

Gross profit (ttm)

130.38M

EBITDA

-36,604,000.00

Net income to common (ttm)

-274,551,008.00

Diluted EPS (ttm)

-6.40

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

66.99M

Total cash per share (mrq)

1.32

Total debt (mrq)

221.94M

Total Debt/Equity (mrq)

318.44

Current ratio (mrq)

117.60%

Book value per share (mrq)

1.38

Cash flow

Cash flow statement

-8,869,000.00

Levered free cash flow (LFCF)

-30,889,624.00